Disclaimer

Our compounded tirzepatide and compounded semaglutide are custom formulations prepared by a licensed compounding pharmacy in the United States to meet individual patient needs pursuant to a prescription for an individual patient. These medications are not the same as the brand-name drugs Ozempic®, Wegovy®, or Mounjaro®, or Zepbound®, which are manufactured by Novo Nordisk and Eli Lilly. Because the medications we offer are compounded formulations for individually identified patients, they have not been reviewed or approved by the U.S. Food and Drug Administration (FDA) for safety or effectiveness.